US0367521038 - Common Stock
Elevance Health Inc. is seeking to sell investment-grade bonds as the big US insurer’s shares have fallen the most since 2020 following a disappointing earnings forecast.
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks.
ELV earnings call for the period ending September 30, 2024.
Elevance Health Inc. shares sank in early trading after the insurer cut its outlook for the year and reported third-quarter profit below Wall Street expectations, citing insufficient payments from Medicaid.
The Dow giant's Optum services unit generated over 50% of operating income.
Humana Medicare Advantage plans are getting a big star-ratings cut.